SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-005886
Filing Date
2018-05-04
Accepted
2018-05-03 17:37:58
Documents
56
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ARBUTUS Q1 2018 10-Q arbutusq12018.htm 10-Q 706148
2 EXHIBIT 10.1 GENEVANT MA exhibit101genevantmasterag.htm EX-10.1 389997
3 EXHIBIT 31.1 CEO CERT exhibit311q12018.htm EX-31.1 13500
4 EXHIBIT 31.2 CFO CERT exhibit312q12018.htm EX-31.2 13991
5 EXHIBIT 32.1 exhibit321q12018.htm EX-32.1 6598
6 EXHIBIT 32.2 exhibit322q12018.htm EX-32.2 6919
13 pipelineapril2018.jpg GRAPHIC 51804
  Complete submission text file 0001628280-18-005886.txt   4178761

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abus-20180331.xml EX-101.INS 616827
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20180331.xsd EX-101.SCH 37108
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20180331_cal.xml EX-101.CAL 59355
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20180331_def.xml EX-101.DEF 154837
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20180331_lab.xml EX-101.LAB 447405
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20180331_pre.xml EX-101.PRE 241486
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 18805173
SIC: 2834 Pharmaceutical Preparations